Ascentage Pharma Group International (AAPG) Total Liabilities: 2022-2024

  • Ascentage Pharma Group International's Total Liabilities fell 4.86% to $321.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $321.1 million, marking a year-over-year decrease of 4.86%. This contributed to the annual value of $321.1 million for FY2024, which is 6.61% down from last year.
  • According to the latest figures from Q4 2024, Ascentage Pharma Group International's Total Liabilities is $321.1 million, which was down 4.86% from $337.5 million recorded in Q4 2023.
  • Ascentage Pharma Group International's 5-year Total Liabilities high stood at $337.5 million for Q4 2023, and its period low was -$57.5 million during Q4 2022.
  • Over the past 3 years, Ascentage Pharma Group International's median Total Liabilities value was $321.1 million (recorded in 2024), while the average stood at $200.4 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first spiked by 687.31% in 2023, then decreased by 4.86% in 2024.
  • Quarterly analysis of 3 years shows Ascentage Pharma Group International's Total Liabilities stood at -$57.5 million in 2022, then soared by 687.31% to $337.5 million in 2023, then decreased by 4.86% to $321.1 million in 2024.
  • Its Total Liabilities was $321.1 million in Q4 2024, compared to $337.5 million in Q4 2023 and -$57.5 million in Q4 2022.